Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rebecca Emory

Nurse Practitioner, Pediatrics Atlanta, GA Nurse Practitioner

NPI 1245798057 CMS profile 11191577

975 Johnson Ferry Rd Ste 340, Atlanta, GA 30342

Open in the dashboard

General payments

$39,770

715 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rebecca Emory of Atlanta, GA is reported in the CMS Open Payments database as having received $39,770 across 715 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,346 241
2024 General $12,893 236
2023 General $7,311 228
2022 General $196 8
2021 General $25 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rebecca Emory
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Rebecca Emory were reported at $19,346. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Rebecca Emory Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $25 $60 $23–$142 $132
2022 $196 $72 $27–$161 $149
2023 $7,311 $89 $35–$185 $160
2024 $12,893 $93 $34–$199 $164
2025 $19,346 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ACADIA Pharmaceuticals Inc $8,237 25 payments
  2. UCB, Inc. $8,226 147 payments
  3. LivaNova USA, Inc. $7,006 34 payments
  4. Catalyst Pharmaceuticals, Inc. $3,700 23 payments
  5. AbbVie, Inc. $1,774 82 payments
  6. Jazz Pharmaceuticals Inc. $1,472 43 payments
  7. Neurelis, Inc. $1,406 46 payments
  8. Pfizer Inc. $1,148 47 payments
  9. Supernus Pharmaceuticals, Inc. $900 29 payments
  10. SK Life Science, Inc. $562 16 payments
  11. Other $5,339 223 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $20,138 683 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,620 11 payments
  3. Travel and Lodging $5,832 18 payments
  4. Consulting Fee $3,680 2 payments
  5. Honoraria $1,500 1 payment
Products named General payments · program years 2021–2025
  1. DAYBUE $8,237 25 payments
  2. Fintepla $4,322 74 payments
  3. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $3,893 17 payments
  4. FYCOMPA $3,572 22 payments
  5. QULIPTA $1,514 66 payments
  6. VNS Therapy Neurology $1,440 5 payments
  7. VALTOCO $1,406 46 payments
  8. Epidiolex $1,351 42 payments
  9. VNS Therapy Cardiology/Vascular Diseases $1,237 5 payments
  10. NURTEC ODT $991 40 payments
  11. Other $9,400 395 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

715 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Pediatrics in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record